1 / 30

ارزیابی نقادانه مقالات مرور سیستماتیک و متاآنالیز ارائه دهندگان: کارشناسان واحد پژوهش

ارزیابی نقادانه مقالات مرور سیستماتیک و متاآنالیز ارائه دهندگان: کارشناسان واحد پژوهش. متاآناليز چیست؟. متاآناليز عبارت است از تركيب داده‌ها و نتايج بدست آمده از يك مرور سيستماتيك با بهره‌گيري از روش‌هاي آماري هدف از انجام مطالعه متاآنالیز : افزایش قدرت افزایش دقت

cantu
Download Presentation

ارزیابی نقادانه مقالات مرور سیستماتیک و متاآنالیز ارائه دهندگان: کارشناسان واحد پژوهش

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ارزیابی نقادانه مقالات مرور سیستماتیک و متاآنالیز ارائه دهندگان: کارشناسان واحد پژوهش

  2. متاآناليز چیست؟ متاآناليز عبارت است از تركيب داده‌ها و نتايج بدست آمده از يك مرور سيستماتيك با بهره‌گيري از روش‌هاي آماري هدف از انجام مطالعه متاآنالیز: • افزایش قدرت • افزایش دقت • پاسخ به سوالات مبهم • حل و فصل تناقض

  3. Title of article • Does thromboprophylaxis reduce symptomatic venous thromboembolism in patients with below knee cast treatment for foot and ankle trauma? A systematic review and meta-analysis • Journal: Foot and Ankle Surgery • Year: 2016 Abstract • Introduction Methods Result • Discussion & • Conclusion

  4. PRISMA 2009 Checklist • Structured summary: • Background & objectives • Methods • Results • Conclusions Abstract • Introduction Methods Result • Discussion & • Conclusion

  5. PRISMA 2009 Checklist • Background: • Our aim was to determine the evidence for thromboprophylaxisfor prevention of symptomatic venous thromboembolism (VTE) in adults with foot or ankle trauma treated with below knee cast or splint. • Our secondary aim was to report major bleeding events. • Methods: • MEDLINE and EMBASE databases were searched for randomized controlled trials from inception to 1st June 2015. Abstract Introduction Methods Result Discussion & Conclusion

  6. PRISMA 2009 Checklist • Results: • Seven studies were included. All focused on low molecular weight heparin (LMWH). • None found a statistically significant symptomatic DVT reduction individually. • At meta-analysis LMWH was protective against symptomatic DVT(OR: 0.29, 95% CI 0.09–0.95). • Symptomatic pulmonary embolism affected 3/692 (0.43%). None were fatal. • 86 patients required LMWH thromboprophylaxisto prevent one symptomatic DVT event. • The overall incidence of major bleeding 0.11% Abstract Introduction Methods Result Discussion & Conclusion

  7. PRISMA 2009 Checklist Conclusions: Low molecular weight heparin reduces the incidence of symptomatic VTE in adult patients with foot or ankle trauma treated with below knee cast or splint. Abstract Introduction Methods Result Discussion & Conclusion

  8. PRISMA 2009 Checklist • Introduction: • Patients with foot and ankle trauma treated with cast or splint immobilization are at risk of venous thromboembolism (VTE). • The most serious complication of this is death from Pulmonary Embolism (1 in 15,000 patients). Abstract • Introduction Methods Result • Discussion & • Conclusion

  9. PRISMA 2009 Checklist • Introduction: • NICE guidelines recommend that patients with foot • and ankle trauma and lower limb immobilization should be assessed for risk of development of VTE, and provided with chemical thromboprophylaxis if they have additional risk factors (including cancer, thrombophilia, previous venous thrombosis) Abstract • Introduction Methods Result • Discussion & • Conclusion

  10. PRISMA 2009 Checklist • Objectives: • Determine the current evidence for the use of chemical or mechanical thromboprophylaxis in the prevention of symptomatic venous thromboembolism in adult patients with foot or ankle trauma treated with below knee cast or splint immobilization. • Our secondary aim was to report episodes of major bleeding associated with thromboprophylaxis. Abstract • Introduction Methods Result • Discussion & • Conclusion

  11. PRISMA 2009 Checklist • Information sources: • The OVID interface was used to search MEDLINE and EMBASE databases up to 1st June 2015. • Search: • search strategy, previously used by Roberts et al. (2012) was used. • Eligibility criteria & Study selection: • The search was limited to randomized controlled trials, with no language exclusions. • Only full papers were reviewed. Abstract • Introduction Methods Result • Discussion & • Conclusion

  12. PRISMA 2009 Checklist Data collection process: • Two reviewers performed data extraction independently using standardized data extraction sheets. • Discrepancies between the reviewers were reviewed by a third reviewer. • Records identified through database searching n =147,812. • Limiting search to Randomized Controlled Trial (RCT) n =1723. • After duplicates removed n = 1364. • Records screened n=1364. • Records excluded n=1353. • Full text articles assessed for eligibility n=11. • Full text articles excluded, with reasons n=4. Abstract • Introduction Methods Result • Discussion & • Conclusion

  13. PRISMA 2009 Checklist Inclusion criteria: • Adult patients of any venous thromboembolism risk stratification (including operative and non-operative treatment) with foot or ankle trauma treated with below knee cast or immobilizing splint. • Study interventions were chemical or mechanical thromboprophylaxis started within 72 h of injury, with a control group, which had nothromboprophylaxis Abstract Introduction Methods Result • Discussion & • Conclusion

  14. PRISMA 2009 Checklist Reason for exclusion: • Study does not have a control group. • Duplicate publication. • No symptomatic VTE events reported. Abstract • Introduction Methods Result • Discussion & • Conclusion

  15. PRISMA 2009 Checklist Data items: • Study(Authors). • Year. • Injuries included and total number of Participant . • Participants included (VTE risk factors). • Exclusion criteria. • Treatment & Treatment group intervention. • Control. • Time between injury and recruitment. • Outcome measure. • Method of objective confirmation of VTE. • Major bleeding, Clinically important non-major bleed, Minor bleed. Abstract • Introduction Methods Result • Discussion & • Conclusion

  16. PRISMA 2009 Checklist Risk of bias in individual studies & Risk of bias across studies: • Risk of bias assessment by Cochrane Risk of Bias tool (Selection bias, Performance bias, Detection bias ,…). • The risk of bias for each article was determined by two authors, who independently reviewed the full articles. Summary measures : • Odds ratio and Absolute Risk Reduction (ARR) for symptomatic DVT were used to calculate number needed to prevent with thromboprophylaxis. • Mantel Haenszel method was used to assess dichotomous outcomes. Abstract • Introduction Methods Result • Discussion & • Conclusion

  17. PRISMA 2009 Checklist Synthesis of results: • Statistical heterogeneity was determined using I square statistics. • Fixed effects model was used when heterogeneity was <30% Abstract • Introduction Methods Result • Discussion & • Conclusion

  18. PRISMA 2009 Checklist • Study selection • Study characteristics • Risk of bias within studies A score from 1 to 3 was given for each of the 7 parameters. • Low risk of bias= score 1 • Risk of bias was deemed unclear= score 2 • High riskbias= score 3 Abstract • Introduction Methods Result • Discussion & • Conclusion

  19. PRISMA 2009 Checklist Results of individual studies: Abstract • Introduction Methods Result • Discussion & • Conclusion Overall incidence was 11/697 (1.58%) in the control group

  20. PRISMA 2009 Checklist Abstract • Introduction Methods Result • Discussion & • Conclusion

  21. PRISMA 2009 Checklist Abstract • Introduction Methods Result • Discussion & • Conclusion Overall symptomatic pulmonary embolism rate considering studies presenting this data was 3/692 (0.43%).

  22. PRISMA 2009 Checklist Abstract • Introduction Methods Result • Discussion & • Conclusion

  23. PRISMA 2009 Checklist Abstract • Introduction Methods Result • Discussion & • Conclusion Overall incidence of major bleeding was 1 in 886 (0.11%), number needed to harm (NNH) = 886.

  24. PRISMA 2009 Checklist Abstract • Introduction Methods Result • Discussion & • Conclusion

  25. PRISMA 2009 Checklist Abstract • Introduction Methods Result • Discussion & • Conclusion

  26. PRISMA 2009 Checklist • LMWH reduces the incidence of symptomatic VTE events in patients with lower limb trauma and below knee cast treatment. • There is a risk of major bleeding (0.11%) which needs to be carefully considered against the benefit of prevention of symptomatic VTE events. Abstract • Introduction Methods Result Discussion & Conclusion

  27. PRISMA 2009 Checklist • The number needed to prevent symptomatic DVT was found to be 86 & 10 symptomatic DVT events would be prevented for every major bleed. • It is also vital to identify which patients in casts are most likely to develop VTE, to enable thromboprophylaxis to be prescribed accurately to those at highest risk. Abstract • Introduction Methods Result Discussion & Conclusion

  28. PRISMA 2009 Checklist • Limitations • unable to determine the precise numbers of patients with additional risk factors for VTE in the included studies because this level of detail was not available from the full texts. • low number of studies included for meta-analysis • none of the studies found significant effects of thromboprophylaxis and are likely to be underpowered Future studies should include sufficient participant numbers to detect true differences between groups and thus the most appropriate way we should be managing these patients. Abstract • Introduction Methods Result Discussion & Conclusion

More Related